Top 10 Vaping Devices to Try in 2021

Jul.27.2022
A list of popular vape kits including the Smok RPM 2, GeekVape Aegis Hero, and Vaporesso Renova Zero.

The following list includes popular vaping devices: Smok RPM 2 80W, GeekVape Aegis Hero, Smok Novo 3, Voopoo Drag S, Mi-Pod 2.06, Innokin Sceptre, Njoy Ace, Suorin Air, Vaporesso Sky Solo, Smok Stick Prince, Vuse Vibe, and Vaporesso Renova Zero.


I'm sorry, but there is no text to translate. Please provide the text for me to translate.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly
1,200 Health Leaders Urge UK Parliament to Pass Tobacco and Vapes Bill Swiftly
Over 1,200 UK health leaders urged Parliament to pass the Tobacco and Vapes Bill quickly, calling it vital to protect future generations. The bill would ban tobacco sales to anyone born after Jan 1, 2009, and restrict vape packaging and flavours. Health groups warned delays risk undermining “gamechanging” public health reforms.
Oct.27 by 2FIRSTS.ai
FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores
FDA Calls on Retailers to Remove Illegal E-Cigarettes from Shelves, Will Send List of Legal Products to 300,000 Stores
FDA launches national retail compliance initiative to combat illegal e-cigarette sales targeting youth, issuing guidance materials to over 300k retailers.
Oct.08 by 2FIRSTS.ai
Ukraine intensifies crackdown on illicit tobacco and alcohol markets
Ukraine intensifies crackdown on illicit tobacco and alcohol markets
Ukraine’s State Tax Service (GNS) has carried out around 24,000 on-site inspections in the tobacco and alcohol sectors this year, imposing more than ₴795 million (US$194 million) in fines and revoking over 2,500 business licences.
Oct.17 by 2FIRSTS.ai
Dutch Ministry of Finance reports: Dutch tobacco tax revenue stagnates, mainly due to cross-border consumption shift
Dutch Ministry of Finance reports: Dutch tobacco tax revenue stagnates, mainly due to cross-border consumption shift
A report released by the Dutch Ministry of Finance indicates that tobacco tax increases have failed to boost fiscal revenue. The previously projected €7 million in revenue from a 5 cent per pack tax increase has now fallen to zero, primarily due to cross-border cigarette purchases. The current excise tax on cigarettes is €7.81 per pack, with no further increases planned. Tobacco tax revenue is projected to reach €2.5 billion in both 2025 and 2026.
Sep.24 by 2FIRSTS.ai
Usonic Dual Launched: China Tobacco Hunan IC and Firstunion Debut Full-Area Thermal Field Technology
Usonic Dual Launched: China Tobacco Hunan IC and Firstunion Debut Full-Area Thermal Field Technology
China Tobacco Hunan IC and Firstunion Group unveiled the Usonic Dual at InterTabac 2025, showcasing a groundbreaking full-area thermal field system and AI-powered interactive design that redefines the heated tobacco experience.
Sep.19
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai